Abstract | BACKGROUND: The majority of patients with breast carcinoma receive chemotherapy as a component of multimodality treatment. Over the past decade, it has become increasingly more common to deliver chemotherapy first, but this has raised new questions within all disciplines of cancer management. METHODS: The authors reviewed published studies on the effect of neoadjuvant chemotherapy for breast carcinoma on the practice of medical oncology, surgical oncology, radiation oncology, pathology, and radiology. RESULTS: CONCLUSIONS: The complexity of the issues led the authors to conclude that patients who receive neoadjuvant chemotherapy are likely to benefit from a coordinated multidisciplinary approach to their care.
|
Authors | Thomas A Buchholz, Kelly K Hunt, Gary J Whitman, Aysegul A Sahin, Gabriel N Hortobagyi |
Journal | Cancer
(Cancer)
Vol. 98
Issue 6
Pg. 1150-60
(Sep 15 2003)
ISSN: 0008-543X [Print] United States |
PMID | 12973838
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Review)
|
Copyright | Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11603 |
Topics |
- Breast Neoplasms
(drug therapy, therapy)
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Female
- Humans
- Neoadjuvant Therapy
- Prospective Studies
- Randomized Controlled Trials as Topic
- Research
|